Zanamivir contraindications

Zanamivir
RELENZA^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
Directions for Use
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sophia Saad, Associate Editor – WikiDoc [2]

Contraindications

Do not use in patients with history of allergic reaction to any ingredient of RELENZA including milk proteins [see Warnings and Precautions (5.2), Description (11)].^[1]

References

↑ “http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021036s019lbl.pdf” (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.

[1] “http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021036s019lbl.pdf” (PDF). External link in |title= (help)

[1]

Zanamivir contraindications

Contraindications

References

Looking for the patient version?